ID   A-375
AC   CVCL_0132
SY   A 375; A375; A375-MEL; A375-mel; A375mel; 375
DR   BTO; BTO_0002806
DR   CLO; CLO_0001544
DR   CLO; CLO_0001581
DR   CLO; CLO_0001582
DR   EFO; EFO_0002103
DR   MCCL; MCC:0000024
DR   CLDB; cl198
DR   CLDB; cl199
DR   Abcam; ab275461
DR   AddexBio; C0020004/4992
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1619
DR   ATCC; CRL-7904
DR   BCRC; 60039
DR   BCRJ; 0278
DR   BioGRID_ORCS_Cell_line; 44
DR   BioSample; SAMN03472142
DR   BioSample; SAMN05292441
DR   BioSample; SAMN07709998
DR   BioSample; SAMN07709999
DR   BioSample; SAMN07710000
DR   BioSample; SAMN07710001
DR   BioSample; SAMN07710002
DR   BioSample; SAMN07710003
DR   BioSample; SAMN07710004
DR   BioSample; SAMN10988347
DR   cancercelllines; CVCL_0132
DR   CCRID; 1101HUM-PUMC000126
DR   CCRID; 1101HUM-PUMC000327
DR   CCRID; 3101HUMSCSP533
DR   CCRID; 3101HUMTCHu155
DR   CCRID; 4201HUM-CCTCC00285
DR   CCTCC; GDC0285
DR   CCTCC; GDC0314
DR   Cell_Model_Passport; SIDM00795
DR   CGH-DB; 9313-4
DR   ChEMBL-Cells; CHEMBL3308077
DR   ChEMBL-Targets; CHEMBL613859
DR   CLS; 300110
DR   Cosmic; 686480
DR   Cosmic; 687431
DR   Cosmic; 706114
DR   Cosmic; 876698
DR   Cosmic; 888861
DR   Cosmic; 897482
DR   Cosmic; 897735
DR   Cosmic; 905226
DR   Cosmic; 906793
DR   Cosmic; 928688
DR   Cosmic; 933003
DR   Cosmic; 1006556
DR   Cosmic; 1022280
DR   Cosmic; 1054855
DR   Cosmic; 1132587
DR   Cosmic; 1155278
DR   Cosmic; 1211162
DR   Cosmic; 1303032
DR   Cosmic; 1458961
DR   Cosmic; 1459655
DR   Cosmic; 1477406
DR   Cosmic; 1481413
DR   Cosmic; 1507620
DR   Cosmic; 1537486
DR   Cosmic; 1555009
DR   Cosmic; 1669118
DR   Cosmic; 1812178
DR   Cosmic; 1888914
DR   Cosmic; 1890486
DR   Cosmic; 1989294
DR   Cosmic; 1995332
DR   Cosmic; 2036699
DR   Cosmic; 2230112
DR   Cosmic; 2233660
DR   Cosmic; 2479252
DR   Cosmic; 2791113
DR   Cosmic-CLP; 906793
DR   DepMap; ACH-000219
DR   ECACC; 88113005
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS606AAA
DR   ENCODE; ENCBS607AAA
DR   GDSC; 906793
DR   GEO; GSM206443
DR   GEO; GSM218051
DR   GEO; GSM274681
DR   GEO; GSM276771
DR   GEO; GSM555121
DR   GEO; GSM555173
DR   GEO; GSM827158
DR   GEO; GSM886854
DR   GEO; GSM887919
DR   GEO; GSM952580
DR   GEO; GSM1092559
DR   GEO; GSM1138787
DR   GEO; GSM1177892
DR   GEO; GSM1177893
DR   GEO; GSM1374382
DR   GEO; GSM1669582
DR   GEO; GSM1671962
DR   GEO; GSM1671967
DR   GEO; GSM1671977
DR   GEO; GSM1671981
DR   GEO; GSM1671982
DR   GEO; GSM1671987
DR   GEO; GSM1671990
DR   GEO; GSM1672001
DR   GEO; GSM1672004
DR   GEO; GSM1672007
DR   GEO; GSM1672011
DR   GEO; GSM1672017
DR   GEO; GSM1672024
DR   GEO; GSM1672027
DR   GEO; GSM1672030
DR   GEO; GSM1672039
DR   GEO; GSM1672051
DR   GEO; GSM1672062
DR   GEO; GSM1672067
DR   GEO; GSM1672078
DR   GEO; GSM1672097
DR   GEO; GSM1672102
DR   GEO; GSM1672119
DR   GEO; GSM1672135
DR   GEO; GSM3039510
DR   GEO; GSM3039516
DR   GEO; GSM3039517
DR   GEO; GSM3039518
DR   IARC_TP53; 21163
DR   IBRC; C10141
DR   IGRhCellID; A375
DR   IZSLER; BS TCL 88
DR   KCB; KCB 99003YJ
DR   LiGeA; CCLE_226
DR   LINCS_HMS; 50060
DR   LINCS_LDP; LCL-1235
DR   Lonza; 970
DR   NCBI_Iran; C136
DR   PharmacoDB; A375_42_2019
DR   PRIDE; PXD001485
DR   PRIDE; PXD004343
DR   PRIDE; PXD005912
DR   PRIDE; PXD007265
DR   PRIDE; PXD021877
DR   PRIDE; PXD022992
DR   PRIDE; PXD025255
DR   PRIDE; PXD025881
DR   PRIDE; PXD026952
DR   PRIDE; PXD027886
DR   PRIDE; PXD028863
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0132
DR   PubChem_Cell_line; CVCL_0132
DR   Ubigene; YC-C036
DR   Wikidata; Q54605986
RX   DOI=10.1007/BF00199208;
RX   DOI=10.1007/BF00205883;
RX   PubMed=77569;
RX   PubMed=265522;
RX   PubMed=327080;
RX   PubMed=375235;
RX   PubMed=833871;
RX   PubMed=1832891;
RX   PubMed=3518877;
RX   PubMed=4357758;
RX   PubMed=6220172;
RX   PubMed=6500159;
RX   PubMed=6584666;
RX   PubMed=6954533;
RX   PubMed=9670966;
RX   PubMed=9973934;
RX   PubMed=10497214;
RX   PubMed=12068308;
RX   PubMed=14871852;
RX   PubMed=15009714;
RX   PubMed=15467732;
RX   PubMed=17308088;
RX   PubMed=18172304;
RX   PubMed=19727395;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21343389;
RX   PubMed=21424129;
RX   PubMed=21673604;
RX   PubMed=21857157;
RX   PubMed=22178978;
RX   PubMed=22282976;
RX   PubMed=22460905;
RX   PubMed=23039341;
RX   PubMed=24581590;
RX   PubMed=25056119;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26405815;
RX   PubMed=26589293;
RX   PubMed=26673621;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29275043;
RX   PubMed=29492214;
RX   PubMed=29605720;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35128241;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=A375
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544560
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/melanoma-xenograft/a375-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 26.9 +- 6.9 hours (PubMed=29275043); ~32 hours (PBCF).
CC   HLA typing: A*01,02; B*12,13 (PubMed=77569).
CC   HLA typing: A*01:01,02:01; B*44:03,57:01; C*06:02,16:02; DQA1*03:02,02:01; DQB1*03:03,03:03; DRB1*04:05,07:01 (PubMed=25960936).
CC   HLA typing: A*01:01,02:01; B*44:03,57:01; C*06:02,16:01; DQA1*03:02,02:01; DQB1*03:02,03:02; DRB1*04:05,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; PubMed=15467732; PubMed=26405815; PubMed=29492214; ATCC=CRL-1619; Cosmic-CLP=906793; DepMap=ACH-000219).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (PubMed=29492214; ATCC=CRL-1619; Cosmic-CLP=906793; DepMap=ACH-000219).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (PubMed=29492214; ATCC=CRL-1619; Cosmic-CLP=906793; DepMap=ACH-000219).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.84%; Native American=0.49%; East Asian, North=1.69%; East Asian, South=0%; South Asian=0%; European, North=67.22%; European, South=29.75% (PubMed=30894373).
CC   Misspelling: A-735; Note=Occasionally.
CC   Discontinued: ATCC; CRL-7904; true.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): AddexBio=C0020004/4992; ATCC=CRL-1619; CCRID; CLS=300110; Cosmic-CLP=906793; ECACC=88113005; IZSLER=BS TCL 88; PubMed=25056119; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 16
ST   D12S391: 18,21
ST   D13S317: 11,14
ST   D16S539: 9
ST   D18S51: 12,17
ST   D19S433: 13,14.2
ST   D1S1656: 16,17.3
ST   D21S11: 29,30
ST   D22S1045: 16
ST   D2S1338: 16,24
ST   D2S441: 11
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 11,14
ST   FGA: 23
ST   Penta D: 9,15
ST   Penta E: 10,12
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
CH   CVCL_6546 ! 4-1.10
CH   CVCL_E8SQ ! A-375 Human CD228
CH   CVCL_E8SR ! A-375 Human CLDN18.2
CH   CVCL_XZ66 ! A-375 Human EGFR vIII
CH   CVCL_UD29 ! A-375 KRAS p.G13D
CH   CVCL_UD28 ! A-375 MEK1 p.Q56P
CH   CVCL_JF22 ! A-375 NRAS p.Q61K
CH   CVCL_C8WV ! A-375-Luc
CH   CVCL_LC86 ! A375 NRAS (Q61K/+/+)
CH   CVCL_C3D8 ! A375 NY-ESO-1 Knockout
CH   CVCL_C0Q6 ! A375 PLX/AZD-resistant
CH   CVCL_E8FX ! A375 RL
CH   CVCL_C3EX ! A375 Safe Harbor Landing Pad
CH   CVCL_C4RR ! A375 XPA-mutated clone A3
CH   CVCL_C4RS ! A375 XPA-mutated clone A9
CH   CVCL_C4RT ! A375 XPA-mutated clone B1
CH   CVCL_2294 ! A375-C5
CH   CVCL_2295 ! A375-C6
CH   CVCL_QZ67 ! A375-eGFP-Puro
CH   CVCL_C8YB ! A375-ER-2
CH   CVCL_QZ68 ! A375-Fluc-Neo/eGFP-Puro
CH   CVCL_QZ69 ! A375-Fluc-Neo/hNIS-Puro
CH   CVCL_QZ70 ! A375-Fluc-Puro
CH   CVCL_QZ71 ! A375-hNIS-Neo/eGFP-Puro
CH   CVCL_QZ72 ! A375-hNIS-Puro
CH   CVCL_QZ73 ! A375-iRFP-Neo
CH   CVCL_QZ74 ! A375-iRFP-Neo/Fluc-Puro
CH   CVCL_QZ75 ! A375-iRFP-Neo/hNIS-Puro
CH   CVCL_B7NR ! A375-Luc-RFP
CH   CVCL_UR32 ! A375-Luc2
CH   CVCL_B222 ! A375-M
CH   CVCL_X494 ! A375-MA1
CH   CVCL_C7GI ! A375-NTP-R
CH   CVCL_6233 ! A375-P
CH   CVCL_6234 ! A375-R
CH   CVCL_A2CR ! A375-R1
CH   CVCL_A1VP ! A375-RMR
CH   CVCL_5649 ! A375-SM
CH   CVCL_AP96 ! A375-VR [2014]
CH   CVCL_AQ00 ! A375-VR [2015]
CH   CVCL_0136 ! A375.S2
CH   CVCL_IW10 ! A375/R
CH   CVCL_R745 ! A375PF11
CH   CVCL_Y439 ! A375S1
CH   CVCL_XE59 ! A375sci
CH   CVCL_B0ZF ! Abcam A-375 IL13RA2 KO
CH   CVCL_B7V4 ! Abcam A-375 NT5E KO
CH   CVCL_KS59 ! CellSensor AP1-bla A375
CH   CVCL_KS16 ! CellSensor SBE-bla A375
CH   CVCL_6286 ! DRO
CH   CVCL_D6AF ! HyCyte A-375 KO-hSETD2
CH   CVCL_E3GK ! HyCyte A-375-Luc
CH   CVCL_ZJ05 ! LanthaScreen ERK2 A375
CH   CVCL_YJ74 ! LINTERNA A375
CH   CVCL_D7J3 ! Ubigene A-375 B2M KO
CH   CVCL_D7J4 ! Ubigene A-375 B3GNT2 KO
CH   CVCL_D7J5 ! Ubigene A-375 IGF2BP1 KO
CH   CVCL_D7J6 ! Ubigene A-375 MAGEA4 KO
CH   CVCL_D7J7 ! Ubigene A-375 PRAME KO
CH   CVCL_D7J9 ! Ubigene A-375 USP7 KO
//
RX   PubMed=6584666; DOI=10.1093/jnci/72.4.913;
RA   Kozlowski, James M.
RA   Hart, Ian R.
RA   Fidler, Isaiah Joshua
RA   Hanna, Nabil
RT   "A human melanoma line heterogeneous with respect to metastatic
RT   capacity in athymic nude mice.";
RL   J. Natl. Cancer Inst. 72:913-917(1984).
//
RX   PubMed=25485619; DOI=10.1038/nbt.3080;
RA   Klijn, Christiaan
RA   Durinck, Steffen
RA   Stawiski, Eric W.
RA   Haverty, Peter M.
RA   Jiang, Zhao-Shi
RA   Liu, Han-Bin
RA   Degenhardt, Jeremiah
RA   Mayba, Oleg
RA   Gnad, Florian
RA   Liu, Jin-Feng
RA   Pau, Gregoire
RA   Reeder, Jens
RA   Cao, Yi
RA   Mukhyala, Kiran
RA   Selvaraj, Suresh K.
RA   Yu, Ma-Mie
RA   Zynda, Gregory J.
RA   Brauer, Matthew J.
RA   Wu, Thomas D.
RA   Gentleman, Robert Clifford
RA   Manning, Gerard
RA   Yauch, Robert L.
RA   Bourgon, Richard
RA   Stokoe, David
RA   Modrusan, Zora
RA   Neve, Richard M.
RA   de Sauvage, Frederic J.
RA   Settleman, Jeffrey
RA   Seshagiri, Somasekar
RA   Zhang, Ze-Min
RT   "A comprehensive transcriptional portrait of human cancer cell
RT   lines.";
RL   Nat. Biotechnol. 33:306-312(2015).
//
RX   PubMed=22178978; DOI=10.1016/j.freeradbiomed.2011.11.019;
RA   Swalwell, Helen
RA   Latimer, Jennifer
RA   Haywood, Rachel M.
RA   Birch-Machin, Mark Anthony
RT   "Investigating the role of melanin in UVA/UVB- and hydrogen
RT   peroxide-induced cellular and mitochondrial ROS production and
RT   mitochondrial DNA damage in human melanoma cells.";
RL   Free Radic. Biol. Med. 52:626-634(2012).
//
RX   PubMed=23039341; DOI=10.1186/1476-4598-11-75; PMCID=PMC3554420;
RA   Byron, Sara A.
RA   Loch, David C.
RA   Wellens, Candice L.
RA   Wortmann, Andreas
RA   Wu, Jia-Yi
RA   Wang, John
RA   Nomoto, Kenichi
RA   Pollock, Pamela M.
RT   "Sensitivity to the MEK inhibitor E6201 in melanoma cells is
RT   associated with mutant BRAF and wildtype PTEN status.";
RL   Mol. Cancer 11:75.1-75.15(2012).
//
RX   PubMed=15467732; DOI=10.1038/sj.onc.1208152;
RA   Tanami, Hideaki
RA   Imoto, Issei
RA   Hirasawa, Akira
RA   Yuki, Yasuhiro
RA   Sonoda, Itaru
RA   Inoue, Jun
RA   Yasui, Kohichiroh
RA   Misawa-Furihata, Akiko
RA   Kawakami, Yutaka
RA   Inazawa, Johji
RT   "Involvement of overexpressed wild-type BRAF in the growth of
RT   malignant melanoma cell lines.";
RL   Oncogene 23:8796-8804(2004).
//
RX   PubMed=375235; DOI=10.1073/pnas.76.3.1288; PMCID=PMC383236;
RA   Sherwin, Stephen A.
RA   Sliski, Ann H.
RA   Todaro, George J.
RT   "Human melanoma cells have both nerve growth factor and nerve growth
RT   factor-specific receptors on their cell surfaces.";
RL   Proc. Natl. Acad. Sci. U.S.A. 76:1288-1292(1979).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675;
RA   Dutil, Julie
RA   Chen, Zhi-Hua
RA   Monteiro, Alvaro N.A.
RA   Teer, Jamie K.
RA   Eschrich, Steven A.
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//
RX   PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981;
RA   Boegel, Sebastian
RA   Lower, Martin
RA   Bukur, Thomas
RA   Sahin, Ugur
RA   Castle, John C.
RT   "A catalog of HLA type, HLA expression, and neo-epitope candidates in
RT   human cancer cell lines.";
RL   OncoImmunology 3:e954893.1-e954893.12(2014).
//
RX   PubMed=29605720; DOI=10.1016/j.neo.2018.02.009; PMCID=PMC5915992;
RA   Mologni, Luca
RA   Costanza, Mariantonia
RA   Sharma, Geeta Geeta
RA   Viltadi, Michela
RA   Massimino, Luca
RA   Citterio, Stefania
RA   Purgante, Stefania
RA   Raman, Hima
RA   Pirola, Alessandra
RA   Zucchetti, Massimo
RA   Piazza, Rocco
RA   Gambacorti-Passerini, Carlo
RT   "Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant
RT   melanoma cells.";
RL   Neoplasia 20:467-477(2018).
//
RX   PubMed=35128241; DOI=10.1021/acsomega.1c05361; PMCID=PMC8811929;
RA   Martinez, Ramon 3rd
RA   Huang, Wei-Liang
RA   Buck, Heather
RA   Rea, Samantha
RA   Defnet, Amy E.
RA   Kane, Maureen A.
RA   Shapiro, Paul
RT   "Proteomic changes in the monolayer and spheroid melanoma cell models
RT   of acquired resistance to BRAF and MEK1/2 inhibitors.";
RL   ACS Omega 7:3293-3311(2022).
//
RX   PubMed=21673604; DOI=10.1097/CMR.0b013e32834495c3; PMCID=PMC3131479;
RA   Orgaz, Jose L.
RA   Benguria, Alberto
RA   Sanchez-Martinez, Cristina
RA   Ladhani, Omar
RA   Volpert, Olga V.
RA   Jimenez, Benilde
RT   "Changes in the gene expression profile of A375 human melanoma cells
RT   induced by overexpression of multifunctional pigment
RT   epithelium-derived factor.";
RL   Melanoma Res. 21:285-297(2011).
//
RX   PubMed=265522; DOI=10.1073/pnas.74.2.565; PMCID=PMC392331;
RA   Fabricant, Robert Neal
RA   De Larco, Joseph E.
RA   Todaro, George J.
RT   "Nerve growth factor receptors on human melanoma cells in culture.";
RL   Proc. Natl. Acad. Sci. U.S.A. 74:565-569(1977).
//
RX   PubMed=327080; DOI=10.1093/jnci/59.1.221;
RA   Fogh, Jorgen
RA   Fogh, Jens M.
RA   Orfeo, Thomas
RT   "One hundred and twenty-seven cultured human tumor cell lines
RT   producing tumors in nude mice.";
RL   J. Natl. Cancer Inst. 59:221-226(1977).
//
RX   PubMed=4357758; DOI=10.1093/jnci/51.5.1417;
RA   Giard, Donald J.
RA   Aaronson, Stuart A.
RA   Todaro, George J.
RA   Arnstein, Paul
RA   Kersey, John H.
RA   Dosik, Harvey
RA   Parks, Wade P.
RT   "In vitro cultivation of human tumors: establishment of cell lines
RT   derived from a series of solid tumors.";
RL   J. Natl. Cancer Inst. 51:1417-1423(1973).
//
RX   PubMed=19727395; DOI=10.1371/journal.pone.0006888; PMCID=PMC2731225;
RA   Wadlow, Raymond Couric
RA   Wittner, Ben S.
RA   Finley, S. Aidan
RA   Bergquist, Henry
RA   Upadhyay, Rabi
RA   Finn, Stephen P.
RA   Loda, Massimo
RA   Mahmood, Umar
RA   Ramaswamy, Sridhar
RT   "Systems-level modeling of cancer-fibroblast interaction.";
RL   PLoS ONE 4:e6888.1-e6888.10(2009).
//
RX   PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878;
RA   Scholtalbers, Jelle
RA   Boegel, Sebastian
RA   Bukur, Thomas
RA   Byl, Marius
RA   Goerges, Sebastian
RA   Sorn, Patrick
RA   Loewer, Martin
RA   Sahin, Ugur
RA   Castle, John C.
RT   "TCLP: an online cancer cell line catalogue integrating HLA type,
RT   predicted neo-epitopes, virus and gene expression.";
RL   Genome Med. 7:118.1-118.7(2015).
//
RX   PubMed=29275043; DOI=10.1016/j.jprot.2017.12.013;
RA   Liberato, Tarcisio
RA   Pessotti, Dayelle S.
RA   Fukushima, Isabella
RA   Kitano, Eduardo S.
RA   Serrano, Solange M.T.
RA   Zelanis, Andre
RT   "Signatures of protein expression revealed by secretome analyses of
RT   cancer associated fibroblasts and melanoma cell lines.";
RL   J. Proteomics 174:1-8(2018).
//
RX   PubMed=77569; DOI=10.1111/j.1399-0039.1978.tb01259.x;
RA   Espmark, Jons Ake
RA   Ahlqvist-Roth, Lena
RA   Sarne, Lena
RA   Persson, Anita
RT   "Tissue typing of cells in culture. III. HLA antigens of established
RT   human cell lines. Attempts at typing by the mixed hemadsorption
RT   technique.";
RL   Tissue Antigens 11:279-286(1978).
//
RX   PubMed=25056119; DOI=10.1158/0008-5472.CAN-14-1232-T; PMCID=PMC4167745;
RA   Watson, Ian R.
RA   Li, Li-Ren
RA   Cabeceiras, Peter K.
RA   Mahdavi, Mozhdeh
RA   Gutschner, Tony
RA   Genovese, Giannicola
RA   Wang, Guo-Can
RA   Fang, Zhuang-Na
RA   Tepper, James M.
RA   Stemke-Hale, Katherine
RA   Tsai, Kenneth Y.
RA   Davies, Michael A.
RA   Mills, Gordon B.
RA   Chin, Lynda
RT   "The RAC1 P29S hotspot mutation in melanoma confers resistance to
RT   pharmacological inhibition of RAF.";
RL   Cancer Res. 74:4845-4852(2014).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469;
RA   Iorio, Francesco
RA   Knijnenburg, Theo A.
RA   Vis, Daniel J.
RA   Bignell, Graham Robert
RA   Menden, Michael Patrick
RA   Schubert, Michael
RA   Aben, Nanne
RA   Goncalves, Emanuel
RA   Barthorpe, Syd
RA   Lightfoot, Howard
RA   Cokelaer, Thomas
RA   Greninger, Patricia
RA   van Dyk, Ewald
RA   Chang, Han
RA   de Silva, Heshani
RA   Heyn, Holger
RA   Deng, Xian-Ming
RA   Egan, Regina K.
RA   Liu, Qing-Song
RA   Mironenko, Tatiana
RA   Mitropoulos, Xeni
RA   Richardson, Laura
RA   Wang, Jin-Hua
RA   Zhang, Ting-Hu
RA   Moran, Sebastian
RA   Sayols, Sergi
RA   Soleimani, Maryam
RA   Tamborero, David
RA   Lopez-Bigas, Nuria
RA   Ross-Macdonald, Petra
RA   Esteller, Manel
RA   Gray, Nathanael S.
RA   Haber, Daniel Arie
RA   Stratton, Michael Rudolf
RA   Benes, Cyril Henri
RA   Wessels, Lodewyk F.A.
RA   Saez-Rodriguez, Julio
RA   McDermott, Ultan
RA   Garnett, Mathew J.
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//
RX   PubMed=26673621; DOI=10.18632/oncotarget.6548; PMCID=PMC4823068;
RA   Roller, Devin Grimm
RA   Capaldo, Brian J.
RA   Bekiranov, Stefan
RA   Mackey, Aaron J.
RA   Conaway, Mark Robert
RA   Petricoin, Emanuel F. 3rd
RA   Gioeli, Daniel
RA   Weber, Michael J.
RT   "Combinatorial drug screening and molecular profiling reveal diverse
RT   mechanisms of intrinsic and adaptive resistance to BRAF inhibition in
RT   V600E BRAF mutant melanomas.";
RL   Oncotarget 7:2734-2753(2016).
//
RX   PubMed=17308088; DOI=10.1158/0008-5472.CAN-06-3311;
RA   Shields, Janiel M.
RA   Thomas, Nancy E.
RA   Cregger, Melissa
RA   Berger, Aaron J.
RA   Leslie, Michael
RA   Torrice, Chad
RA   Hao, Hong-Lin
RA   Penland, Shannon
RA   Arbiser, Jack Leonard
RA   Scott, Glynis A.
RA   Zhou, Tong
RA   Bar-Eli, Menashe
RA   Bear, James E.
RA   Der, Channing Joseph
RA   Kaufmann, William K.
RA   Rimm, David L.
RA   Sharpless, Norman Edward
RT   "Lack of extracellular signal-regulated kinase mitogen-activated
RT   protein kinase signaling shows a new type of melanoma.";
RL   Cancer Res. 67:1502-1512(2007).
//
RX   PubMed=14871852; DOI=10.1158/0008-5472.CAN-03-2209;
RA   Hogan, Kevin T.
RA   Coppola, Michael A.
RA   Gatlin, Christine L.
RA   Thompson, Lee W.
RA   Shabanowitz, Jeffrey
RA   Hunt, Donald Frederick
RA   Engelhard, Victor H.
RA   Ross, Mark M.
RA   Slingluff, Craig L. Jr.
RT   "Identification of novel and widely expressed cancer/testis gene
RT   isoforms that elicit spontaneous cytotoxic T-lymphocyte reactivity to
RT   melanoma.";
RL   Cancer Res. 64:1157-1163(2004).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu, Ma-Mie
RA   Selvaraj, Suresh K.
RA   Liang-Chu, May M.Y.
RA   Aghajani, Sahar
RA   Busse, Matthew
RA   Yuan, Jean
RA   Lee, Genee
RA   Peale, Franklin V.
RA   Klijn, Christiaan
RA   Bourgon, Richard
RA   Kaminker, Joshua S.
RA   Neve, Richard M.
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=31978347; DOI=10.1016/j.cell.2019.12.023; PMCID=PMC7339254;
RA   Nusinow, David Paul
RA   Szpyt, John
RA   Ghandi, Mahmoud
RA   Rose, Christopher M.
RA   McDonald, E. Robert 3rd
RA   Kalocsay, Marian
RA   Jane-Valbuena, Judit
RA   Gelfand, Ellen T.
RA   Schweppe, Devin K.
RA   Jedrychowski, Mark P.
RA   Golji, Javad
RA   Porter, Dale A.
RA   Rejtar, Tomas
RA   Wang, Y. Karen
RA   Kryukov, Gregory V.
RA   Stegmeier, Frank
RA   Erickson, Brian K.
RA   Garraway, Levi Alexander
RA   Sellers, William Raj
RA   Gygi, Steven P.
RT   "Quantitative proteomics of the Cancer Cell Line Encyclopedia.";
RL   Cell 180:387-402.e16(2020).
//
RX   PubMed=22282976; DOI=10.1093/carcin/1.1.21;
RA   Day, Rufus S. 3rd
RA   Ziolkowski, Chuck H.J.
RA   Scudiero, Dominic A.
RA   Meyer, Sharon A.
RA   Mattern, Michael R.
RT   "Human tumor cell strains defective in the repair of alkylation
RT   damage.";
RL   Carcinogenesis 1:21-32(1980).
//
RX   PubMed=30971826; DOI=10.1038/s41586-019-1103-9;
RA   Behan, Fiona M.
RA   Iorio, Francesco
RA   Picco, Gabriele
RA   Goncalves, Emanuel
RA   Beaver, Charlotte M.
RA   Migliardi, Giorgia
RA   Santos, Rita
RA   Rao, Yanhua
RA   Sassi, Francesco
RA   Pinnelli, Marika
RA   Ansari, Rizwan
RA   Harper, Sarah
RA   Jackson, David Adam
RA   McRae, Rebecca
RA   Pooley, Rachel
RA   Wilkinson, Piers
RA   van der Meer, Dieudonne J.
RA   Dow, David
RA   Buser-Doepner, Carolyn A.
RA   Bertotti, Andrea
RA   Trusolino, Livio
RA   Stronach, Euan Alexander
RA   Saez-Rodriguez, Julio
RA   Yusa, Kosuke
RA   Garnett, Mathew J.
RT   "Prioritization of cancer therapeutic targets using CRISPR-Cas9
RT   screens.";
RL   Nature 568:511-516(2019).
//
RX   PubMed=6954533; DOI=10.1073/pnas.79.7.2194; PMCID=PMC346157;
RA   Westin, Eric H.
RA   Gallo, Robert Charles
RA   Arya, Suresh K.
RA   Eva, Alessandra
RA   Souza, Lawrence M.
RA   Baluda, Marcel Albert
RA   Aaronson, Stuart A.
RA   Wong-Staal, Flossie
RT   "Differential expression of the amv gene in human hematopoietic
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:2194-2198(1982).
//
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh, Jorgen
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
//
RX   PubMed=21343389; DOI=10.1158/0008-5472.CAN-10-2958; PMCID=PMC3070783;
RA   Rose, Amy E.
RA   Poliseno, Laura
RA   Wang, Jin-Hua
RA   Clark, Michael
RA   Pearlman, Alexander
RA   Wang, Gui-Min
RA   Vega y Saenz de Miera, Eleazar Carmelo
RA   Medicherla, Ratna
RA   Christos, Paul J.
RA   Shapiro, Richard
RA   Pavlick, Anna
RA   Darvishian, Farbod
RA   Zavadil, Jiri
RA   Polsky, David
RA   Hernando, Eva
RA   Ostrer, Harry
RA   Osman, Iman
RT   "Integrative genomics identifies molecular alterations that challenge
RT   the linear model of melanoma progression.";
RL   Cancer Res. 71:2561-2571(2011).
//
RX   PubMed=9973934; DOI=10.1016/S0165-4608(98)00122-8;
RA   Nelson, Mark A.
RA   Ariza, Maria E.
RA   Yang, Jin-Ming
RA   Thompson, Floyd H.
RA   Taetle, Raymond
RA   Trent, Jeffrey M.
RA   Wymer, Julie
RA   Massey-Brown, Kathy S.
RA   Broome-Powell, Marianne
RA   Easton, John
RA   Lahti, Jill M.
RA   Kidd, Vincent J.
RT   "Abnormalities in the p34cdc2-related PITSLRE protein kinase gene
RT   complex (CDC2L) on chromosome band 1p36 in melanoma.";
RL   Cancer Genet. Cytogenet. 108:91-99(1999).
//
RX   PubMed=6220172;
RA   Dracopoli, Nicholas C.
RA   Fogh, Jorgen
RT   "Polymorphic enzyme analysis of cultured human tumor cell lines.";
RL   J. Natl. Cancer Inst. 70:469-476(1983).
//
RX   PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775;
RA   Goncalves, Emanuel
RA   Poulos, Rebecca C.
RA   Cai, Zhao-Xiang
RA   Barthorpe, Syd
RA   Manda, Srikanth S.
RA   Lucas, Natasha
RA   Beck, Alexandra
RA   Bucio-Noble, Daniel
RA   Dausmann, Michael
RA   Hall, Caitlin
RA   Hecker, Michael
RA   Koh, Jennifer
RA   Lightfoot, Howard
RA   Mahboob, Sadia
RA   Mali, Iman
RA   Morris, James
RA   Richardson, Laura
RA   Seneviratne, Akila J.
RA   Shepherd, Rebecca
RA   Sykes, Erin
RA   Thomas, Frances
RA   Valentini, Sara
RA   Williams, Steven G.
RA   Wu, Yang-Xiu
RA   Xavier, Dylan
RA   MacKenzie, Karen L.
RA   Hains, Peter G.
RA   Tully, Brett
RA   Robinson, Phillip James
RA   Zhong, Qing
RA   Garnett, Mathew J.
RA   Reddel, Roger Robert
RT   "Pan-cancer proteomic map of 949 human cell lines.";
RL   Cancer Cell 40:835-849.e8(2022).
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662;
RA   Rothenberg, S. Michael
RA   Mohapatra, Gayatry
RA   Rivera, Miguel N.
RA   Winokur, Daniel
RA   Greninger, Patricia
RA   Nitta, Mai
RA   Sadow, Peter M.
RA   Sooriyakumar, Gaya
RA   Brannigan, Brian W.
RA   Ulman, Matthew J.
RA   Perera, Rushika M.
RA   Wang, Rui
RA   Tam, Angela
RA   Ma, Xiao-Jun
RA   Erlander, Mark
RA   Sgroi, Dennis C.
RA   Rocco, James W.
RA   Lingen, Mark W.
RA   Cohen, Ezra E.W.
RA   Louis, David Neil
RA   Settleman, Jeffrey
RA   Haber, Daniel Arie
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//
RX   DOI=10.1007/BF00199208;
RA   Bruggen, Josef
RA   Sorg, Clemens
RA   Macher, Egon
RT   "Membrane associated antigens of human malignant melanoma V:
RT   Serological typing of cell lines using antisera from nonhuman
RT   primates.";
RL   Cancer Immunol. Immunother. 5:53-62(1978).
//
RX   PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027;
RA   Barretina, Jordi Ginesta
RA   Caponigro, Giordano
RA   Stransky, Nicolas
RA   Venkatesan, Kavitha
RA   Margolin, Adam A.
RA   Kim, Sungjoon
RA   Wilson, Christopher J.
RA   Lehar, Joseph
RA   Kryukov, Gregory V.
RA   Sonkin, Dmitriy
RA   Reddy, Anupama
RA   Liu, Manway
RA   Murray, Lauren
RA   Berger, Michael F.
RA   Monahan, John E.
RA   Morais, Paula
RA   Meltzer, Jodi
RA   Korejwa, Adam
RA   Jane-Valbuena, Judit
RA   Mapa, Felipa A.
RA   Thibault, Joseph
RA   Bric-Furlong, Eva
RA   Raman, Pichai
RA   Shipway, Aaron
RA   Engels, Ingo H.
RA   Cheng, Jill
RA   Yu, Guo-Ying K.
RA   Yu, Jian-Jun
RA   Aspesi, Peter Jr.
RA   de Silva, Melanie
RA   Jagtap, Kalpana
RA   Jones, Michael D.
RA   Wang, Li
RA   Hatton, Charles
RA   Palescandolo, Emanuele
RA   Gupta, Supriya
RA   Mahan, Scott
RA   Sougnez, Carrie
RA   Onofrio, Robert C.
RA   Liefeld, Ted
RA   MacConaill, Laura E.
RA   Winckler, Wendy
RA   Reich, Michael
RA   Li, Nan-Xin
RA   Mesirov, Jill P.
RA   Gabriel, Stacey B.
RA   Getz, Gad
RA   Ardlie, Kristin
RA   Chan, Vivien
RA   Myer, Vic E.
RA   Weber, Barbara L.
RA   Porter, Jeff
RA   Warmuth, Markus
RA   Finan, Peter
RA   Harris, Jennifer L.
RA   Meyerson, Matthew Langer
RA   Golub, Todd Robert
RA   Morrissey, Michael P.
RA   Sellers, William Raj
RA   Schlegel, Robert
RA   Garraway, Levi Alexander
RT   "The Cancer Cell Line Encyclopedia enables predictive modelling of
RT   anticancer drug sensitivity.";
RL   Nature 483:603-607(2012).
//
RX   PubMed=9670966; DOI=10.4049/jimmunol.161.2.877;
RA   Bettinotti, Maria P.
RA   Kim, Christina J.
RA   Lee, Kang-Hun
RA   Roden, Matthew
RA   Cormier, Janice N.
RA   Panelli, Monica C.
RA   Parker, Kenneth K.
RA   Marincola, Francesco M.
RT   "Stringent allele/epitope requirements for MART-1/Melan A
RT   immunodominance: implications for peptide-based immunotherapy.";
RL   J. Immunol. 161:877-889(1998).
//
RX   PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113;
RA   Bignell, Graham Robert
RA   Greenman, Christopher D.
RA   Davies, Helen R.
RA   Butler, Adam P.
RA   Edkins, Sarah
RA   Andrews, Jenny M.
RA   Buck, Gemma
RA   Chen, Lina
RA   Beare, David
RA   Latimer, Calli
RA   Widaa, Sara
RA   Hinton, Jonathan
RA   Fahey, Ciara
RA   Fu, Bei-Yuan
RA   Swamy, Sajani
RA   Dalgliesh, Gillian L.
RA   Teh, Bin Tean
RA   Deloukas, Panos
RA   Yang, Feng-Tang
RA   Campbell, Peter J.
RA   Futreal, P. Andrew
RA   Stratton, Michael Rudolf
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076;
RA   Li, Jun
RA   Zhao, Wei
RA   Akbani, Rehan
RA   Liu, Wen-Bin
RA   Ju, Zhen-Lin
RA   Ling, Shi-Yun
RA   Vellano, Christopher P.
RA   Roebuck, Paul
RA   Yu, Qing-Hua
RA   Eterovic, A. Karina
RA   Byers, Lauren Averett
RA   Davies, Michael A.
RA   Deng, Wan-Leng
RA   Gopal, Y.N. Vashisht
RA   Chen, Guo
RA   von Euw, Erika Maria
RA   Slamon, Dennis Joseph
RA   Conklin, Dylan
RA   Heymach, John Victor
RA   Gazdar, Adi F.
RA   Minna, John D.
RA   Myers, Jeffrey N.
RA   Lu, Yi-Ling
RA   Mills, Gordon B.
RA   Liang, Han
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103;
RA   Ghandi, Mahmoud
RA   Huang, Franklin W.
RA   Jane-Valbuena, Judit
RA   Kryukov, Gregory V.
RA   Lo, Christopher C.
RA   McDonald, E. Robert 3rd
RA   Barretina, Jordi Ginesta
RA   Gelfand, Ellen T.
RA   Bielski, Craig M.
RA   Li, Hao-Xin
RA   Hu, Kevin
RA   Andreev-Drakhlin, Alexander Y.
RA   Kim, Jaegil
RA   Hess, Julian M.
RA   Haas, Brian J.
RA   Aguet, Francois
RA   Weir, Barbara A.
RA   Rothberg, Michael V.
RA   Paolella, Brenton R.
RA   Lawrence, Michael Scott
RA   Akbani, Rehan
RA   Lu, Yi-Ling
RA   Tiv, Hong L.
RA   Gokhale, Prafulla C.
RA   de Weck, Antoine
RA   Mansour, Ali Amin
RA   Oh, Coyin
RA   Shih, Juliann
RA   Hadi, Kevin
RA   Rosen, Yanay
RA   Bistline, Jonathan
RA   Venkatesan, Kavitha
RA   Reddy, Anupama
RA   Sonkin, Dmitriy
RA   Liu, Manway
RA   Lehar, Joseph
RA   Korn, Joshua M.
RA   Porter, Dale A.
RA   Jones, Michael D.
RA   Golji, Javad
RA   Caponigro, Giordano
RA   Taylor, Jordan E.
RA   Dunning, Caitlin M.
RA   Creech, Amanda L.
RA   Warren, Allison C.
RA   McFarland, James M.
RA   Zamanighomi, Mahdi
RA   Kauffmann, Audrey
RA   Stransky, Nicolas
RA   Imielinski, Marcin
RA   Maruvka, Yosef E.
RA   Cherniack, Andrew D.
RA   Tsherniak, Aviad
RA   Vazquez, Francisca
RA   Jaffe, Jacob D.
RA   Lane, Andrew Alan
RA   Weinstock, David M.
RA   Johannessen, Cory M.
RA   Morrissey, Michael P.
RA   Stegmeier, Frank
RA   Schlegel, Robert
RA   Hahn, William Chun
RA   Getz, Gad
RA   Mills, Gordon B.
RA   Boehm, Jesse S.
RA   Golub, Todd Robert
RA   Garraway, Levi Alexander
RA   Sellers, William Raj
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//
RX   PubMed=10497214; DOI=10.1074/jbc.274.40.28505;
RA   Ariza, Maria E.
RA   Broome-Powell, Marianne
RA   Lahti, Jill M.
RA   Kidd, Vincent J.
RA   Nelson, Mark A.
RT   "Fas-induced apoptosis in human malignant melanoma cell lines is
RT   associated with the activation of the p34(cdc2)-related PITSLRE
RT   protein kinases.";
RL   J. Biol. Chem. 274:28505-28513(1999).
//
RX   PubMed=15009714; DOI=10.1046/j.0022-202X.2004.22243.x; PMCID=PMC2586668;
RA   Tsao, Hensin
RA   Goel, Vikas
RA   Wu, Heng
RA   Yang, Guang
RA   Haluska, Frank G.
RT   "Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1
RT   inactivation in melanoma.";
RL   J. Invest. Dermatol. 122:337-341(2004).
//
RX   PubMed=1832891; DOI=10.1016/0277-5379(91)90277-K;
RA   Hansson, Johan
RA   Fichtinger-Schepman, Anne Marie Josephine
RA   Edgren, Margareta R.
RA   Ringborg, Ulrik
RT   "Comparative study of two human melanoma cell lines with different
RT   sensitivities to mustine and cisplatin.";
RL   Eur. J. Cancer 27:1039-1045(1991).
//
RX   PubMed=24581590; DOI=10.1016/j.jdermsci.2014.01.006;
RA   Gehrke, Samuel
RA   Otsuka, Atsushi
RA   Huber, Roman
RA   Meier, Barbara
RA   Kistowska, Magdalena
RA   Fenini, Gabriele
RA   Cheng, Phil
RA   Dummer, Reinhard
RA   Kerl, Katrin
RA   Contassot, Emmanuel
RA   French, Lars Einar
RT   "Metastatic melanoma cell lines do not secrete IL-1beta but promote
RT   IL-1beta production from macrophages.";
RL   J. Dermatol. Sci. 74:167-169(2014).
//
RX   PubMed=21424129; DOI=10.3892/or.2011.1220;
RA   Manca, Antonella
RA   Sini, Maria Cristina
RA   Izzo, Francesco
RA   Ascierto, Paolo Antonio
RA   Tatangelo, Fabiana
RA   Botti, Gerardo
RA   Gentilcore, Giusy
RA   Capone, Marilena
RA   Mozzillo, Nicola
RA   Rozzo, Carla
RA   Cossu, Antonio
RA   Tanda, Francesco
RA   Palmieri, Giuseppe
RT   "Induction of arginosuccinate synthetase (ASS) expression affects the
RT   antiproliferative activity of arginine deiminase (ADI) in melanoma
RT   cells.";
RL   Oncol. Rep. 25:1495-1502(2011).
//
RX   PubMed=26405815; DOI=10.1371/journal.pone.0138210; PMCID=PMC4583389;
RA   Capaldo, Brian J.
RA   Roller, Devin Grimm
RA   Axelrod, Mark J.
RA   Koeppel, Alexander F.
RA   Petricoin, Emanuel F. 3rd
RA   Slingluff, Craig L. Jr.
RA   Weber, Michael J.
RA   Mackey, Aaron J.
RA   Gioeli, Daniel
RA   Bekiranov, Stefan
RT   "Systems analysis of adaptive responses to MAP kinase pathway blockade
RT   in BRAF mutant melanoma.";
RL   PLoS ONE 10:e0138210.1-e0138210.25(2015).
//
RX   PubMed=6500159; DOI=10.1159/000163283;
RA   Gershwin, Merrill Eric
RA   Lentz, Daniel
RA   Owens, Robert B.
RT   "Relationship between karyotype of tissue culture lines and
RT   tumorigenicity in nude mice.";
RL   Exp. Cell Biol. 52:361-370(1984).
//
RX   DOI=10.1007/BF00205883;
RA   Bruggen, Josef
RA   Macher, Egon
RA   Sorg, Clemens
RT   "Expression of surface antigens and its relation to parameters of
RT   malignancy in human malignant melanoma.";
RL   Cancer Immunol. Immunother. 10:121-127(1981).
//
RX   PubMed=12068308; DOI=10.1038/nature00766;
RA   Davies, Helen R.
RA   Bignell, Graham Robert
RA   Cox, Charles
RA   Stephens, Philip J.
RA   Edkins, Sarah
RA   Clegg, Sheila
RA   Teague, Jon W.
RA   Woffendin, Hayley
RA   Garnett, Mathew J.
RA   Bottomley, William
RA   Davis, Neil
RA   Dicks, Ed
RA   Ewing, Rebecca
RA   Floyd, Yvonne
RA   Gray, Kristian
RA   Hall, Sarah
RA   Hawes, Rachel
RA   Hughes, Jaime
RA   Kosmidou, Vivian
RA   Menzies, Andrew
RA   Mould, Catherine
RA   Parker, Adrian
RA   Stevens, Claire
RA   Watt, Stephen
RA   Hooper, Steven
RA   Wilson, Rebecca
RA   Jayatilake, Hiran
RA   Gusterson, Barry Austin
RA   Cooper, Colin S.
RA   Shipley, Janet M.
RA   Hargrave, Darren
RA   Pritchard-Jones, Kathy
RA   Maitland, Norman J.
RA   Chenevix-Trench, Georgia
RA   Riggins, Gregory J.
RA   Bigner, Darell Doty
RA   Palmieri, Giuseppe
RA   Cossu, Antonio
RA   Flanagan, Adrienne M.
RA   Nicholson, Andrew
RA   Ho, Judy W.C.
RA   Leung, Suet Yi
RA   Yuen, Siu Tsan
RA   Weber, Barbara L.
RA   Seigler, Hilliard Foster
RA   Darrow, Timothy L.
RA   Paterson, Hugh F.
RA   Marais, Richard
RA   Marshall, Christopher John
RA   Wooster, Richard
RA   Stratton, Michael Rudolf
RA   Futreal, P. Andrew
RT   "Mutations of the BRAF gene in human cancer.";
RL   Nature 417:949-954(2002).
//
RX   PubMed=18172304; DOI=10.1158/0008-5472.CAN-07-1939;
RA   Sabatino, Marianna
RA   Zhao, Ying-Dong
RA   Voiculescu, Sonia
RA   Monaco, Alessandro
RA   Robbins, Paul F.
RA   Karai, Laszlo
RA   Nickoloff, Brian J.
RA   Maio, Michele
RA   Selleri, Silvia
RA   Marincola, Francesco M.
RA   Wang, Ena
RT   "Conservation of genetic alterations in recurrent melanoma supports
RT   the melanoma stem cell hypothesis.";
RL   Cancer Res. 68:122-131(2008).
//
RX   PubMed=29492214; DOI=10.18632/oncotarget.23989; PMCID=PMC5823576;
RA   Sini, Maria Cristina
RA   Doneddu, Valentina
RA   Paliogiannis, Panagiotis
RA   Casula, Milena
RA   Colombino, Maria
RA   Manca, Antonella
RA   Botti, Gerardo
RA   Ascierto, Paolo Antonio
RA   Lissia, Amelia
RA   Cossu, Antonio
RA   Palmieri, Giuseppe
RT   "Genetic alterations in main candidate genes during melanoma
RT   progression.";
RL   Oncotarget 9:8531-8541(2018).
//
RX   PubMed=833871; DOI=10.1093/jnci/58.2.209;
RA   Fogh, Jorgen
RA   Wright, William C.
RA   Loveless, James D.
RT   "Absence of HeLa cell contamination in 169 cell lines derived from
RT   human tumors.";
RL   J. Natl. Cancer Inst. 58:209-214(1977).
//
RX   PubMed=21857157; DOI=10.4161/cc.10.17.17068; PMCID=PMC5479465;
RA   Caputo, Emilia
RA   Maiorana, Luigi
RA   Vasta, Valeria
RA   Pezzino, Franca Maria
RA   Sunkara, Sudhir
RA   Wynne, Kieran
RA   Elia, Giuliano
RA   Marincola, Francesco M.
RA   McCubrey, James Andrew
RA   Libra, Massimo
RA   Travali, Salvatore
RA   Kane, Marian
RT   "Characterization of human melanoma cell lines and melanocytes by
RT   proteome analysis.";
RL   Cell Cycle 10:2924-2936(2011).
//